UTMD earnings: real EPS beat/miss history, P/E 20.97. Updated 2026-07-23.
Utah Medical Products (UTMD) Research Hub
Utah Medical Products (UTMD) trades on NASDAQ, US in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-09-11, shares last closed at 69.71 USD (-0.01%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 20.97, market cap 0.22B. This hub links to the full technical, earnings and options research available for UTMD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 69.71 USD (-0.01%) |
| 52-week range | 64.77 USD – 75.75 USD |
| Trend regime | Range |
| 14-day RSI | 45.7 (Neutral) |
| Trailing P/E | 20.97 |
| Market cap | 0.22B |
| Dividend yield | 1.78% |
Available research for UTMD
Covered Call on UTMD: how it works, illustrative setup around the real 69.71 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on UTMD: how it works, illustrative setup around the real 69.71 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on UTMD: how it works, illustrative setup around the real 69.71 USD price, max profit/loss, breakeven and when to use it. Educational.
UTMD technical analysis: range, last 69.71 USD, RSI 45.7, 52w range 64.77 USD–75.75 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is UTMD in?
Utah Medical Products (UTMD) is classified under Healthcare (Medical - Instruments & Supplies), listed on NASDAQ, US.
Is UTMD in an uptrend or downtrend?
As of 2026-09-11, UTMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is UTMD's trailing P/E ratio?
UTMD's trailing P/E is 20.97, with a market cap of 0.22B. See the earnings research page for full valuation detail.